Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 6Phase NA 4Phase 2/3 2Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Polyps 1Neoplasms 1Colorectal Neoplasms 1Adenomatous Polyps 1Adenoma 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Calcium Carbonate × Clear all
NCT01052051 2019-07-24

CAPS

Creighton University

Phase 2/3 Completed
2,303 enrolled
Tumor-Agnostic

Neoplasms

NCT00153816 2017-03-15

Vitamin D/Calcium Polyp Prevention Study

Dartmouth-Hitchcock Medical Center

Phase 2/3 Completed
2,813 enrolled 15 charts
Gastrointestinal

Adenoma, Polyps, Colorectal Neoplasms, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡